Trial Profile
PMI 001 as stand-alone therapy in patients with rheumatoid arthritis: second of three US-based phase III trials
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 03 May 2010
Price :
$35
*
At a glance
- Drugs Tripterygium wilfordii Hook F (Primary)
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- 03 May 2010 New trial record.